Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health

NCT00892762 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

434

Enrollment

INDUSTRY

Sponsor class

Conditions

Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Travoprost APS 40 micrograms/ml eye drop solution
DRUG: Latanoprost 50 micrograms/ml eye drop solution

Sponsor

Alcon Research